(2)
|
*This course qualifies for ProAssurance Premium Credit.
Release Date: May 24, 2023
Review Date: May 12, 2023
Expiration Date: May 24, 2026
This on-demand course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for continuing education on responsible opioid prescribing per Med 13.03(3) of the Wisconsin Administrative Code. This course meets the two-hour requirement and can be combined with additional education to meet the one-time, 8-hour training requirement outlined in the MATE Act.
This activity has been pre-approved for ABA, ABIM, ABOS, ABOHNS, ABP, ABPath, ABS, and ABTS MOC Part II credit. Approval for MOC Part II credit by other ABMS Boards may be found at https://www.abms.org/. Participants who complete the activity by December 1 will have their MOC credit submitted for the current year; submissions received after December 1 will have MOC credits reported for the following year.
Speaker
Michael M. Miller, MD, DFASAM, DLFAPA, Associate Clinical Professor, Medical College of Wisconsin
Description
Pain and addiction are both commonly experienced conditions that are under-recognized in general medical settings. This presentation takes a societal view of the opioid epidemic addressing the policy and regulatory landscape to ensure adherence to safe prescribing practices and prescribers’ roles as promoters of public health with respect to opioids.
Method of Participation
Prior to viewing the presentation, participants must complete a brief pre-test. Participants view the presentation and listen to the synchronized audio of the recorded lecture. After viewing the presentation, participants must complete an evaluation and a post-test in which they must answer at least 75% of the answers correctly in order to receive AMA PRA Category 1 Credit™. The participant cannot proceed to request credit until this score is achieved.
Objectives
Following this presentation, learners should be able to:
• Describe the role of physicians and other prescribers in the evolution of the opioid epidemic
• Outline the role of licensure boards in influencing licensees’ clinical performance regarding opioids
• Embrace their role as promoters of public health with respect to opioids’ safe use
Contact Information
Email education@wismed.org for questions related to the educational content.
Target Audience
This activity is designed for Primary Care Physicians, Specialty Physicians, Physician Assistants, Nurse Practitioners, Allied Health Professionals, Nurses, Social Workers, and Professional Staff
Commercial Support
No commercial support was used in creating this educational activity.
ADA Compliance Statement
In accordance with the Americans with Disabilities Act, the Wisconsin Medical Society seeks to make this activity accessible to all. If you have a disability, which might require special accommodations, please call 608.442.3800.
Refund policy
Registration is not refundable. If you are unable to participate in an activity for which you are registered, you may have a substitute participate in your place.
Disclosure Statement
None of the faculty or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.